NCT02161276

Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule

Phase 2 Study of The Optimal Dosage of Tang Ning Tongluo Capsule for Type II Diabetes

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 110 (actual)
• Sponsor: Guizhou Bailing Group Pharmaceutical Co Ltd · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Treatment of diabetes mellitus with Traditional Chinese Medicine has a long history. aim： --establish the optimal dosage of traditional Chinese medicine Tang Ning Tongluo Capsule to treat type II diabetes mellitus. ---Preliminary evaluate the clinical efficacy and safety of Tangning Tongluo Capsule in the treatment of type II diabetes

Detailed description

Preliminary evaluation on the clinical efficacy and safety of Tangning Tongluo Capsule in the treatment of type II diabetes, and provides basis for determining optimal dosage of Tangning Tongluo capsule.

Conditions

• Accidental Exposure While Preparing Drug for Administration

Interventions

Type	Name	Description
DRUG	TNTL capsule	Patients were asked to taken drugs 3 times a day, with each time 3 grains
DRUG	Placebo	Patients were asked to taken drugs 3 times a day, with each time 3 grains

Timeline

• Start date: 2014-04-01
• Primary completion: 2014-08-01
• Completion: 2014-09-01
• First posted: 2014-06-11
• Last updated: 2014-09-11

Locations

1 site across 1 country: China